A Simple Method for Grading Breast Tumors
Author Information
Author(s): Kristian Wennmalm, Jonas Bergh
Primary Institution: Karolinska Institutet
Hypothesis
Can a method that uses only the breast tumor profile improve the grading of breast cancer?
Conclusion
The study validates a new microarray-based grading method for breast cancer that could improve recurrence risk estimation for many patients.
Supporting Evidence
- The method achieved 83-94% accuracy for low grade tumors and 74-100% for high grade tumors.
- Two groups of intermediate grade cancers with significantly different outcomes were identified.
- The study included validation in 594 patients from independent data sets.
Takeaway
This study found a new way to grade breast cancer tumors using a simple method that could help doctors better understand how serious the cancer is.
Methodology
The study optimized a rank-based algorithm using gene expression data from breast tumors to classify them into genomic grades.
Potential Biases
There is a potential bias towards low genomic grade classification due to the removal of lowly expressed genes.
Limitations
The method may be sensitive to differences in average expression between probes.
Participant Demographics
The study included breast cancer patients from various cohorts, with a focus on histopathologically graded tumors.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website